Also in this playlist...
This transcript is automatically generated
You to a company you might not of heard of before but it is huge Sigma-Aldrich.
It's a highly profitable ten billion dollar bio chemical developer.
And it's off to a very strong start this year it shares up nearly 15%.
Year to date for -- soft and is sick my altered CEO and president.
We want to bring the men.
Because this is a company -- every single drug that's now on the market.
Cuts at least one of your chemical compounds in a that's fascinating to me as we said well let's bring in the guy who makes the actual -- -- but going to these famous drug.
Well just to clarify you know we we sell our products into the lights -- still industry and -- products are used by researchers.
As well as manufacturers alongside some products in the life -- space.
I would say that we have been very instrumental in helping -- -- Biopharma companies develop new drugs and I would say that.
Almost every drug that's on the marketplace -- -- at some point at some be used saying martyrs products to develop those drugs -- It's it's to me the -- the basis the foundation of all the drugs out there and we -- yourselves this is a company we should be looking at.
Because not only do you do business here in the US but 70% of your business -- ex US outside the united Stewart's.
Which principally to the question where do you see the real growth when it comes to life sciences research and development.
You know -- I'm so has a strategic place and almost every country and say even many think of places like Asia Pacific.
In -- countries like China and India and other places have made life sciences a strategic agenda item on their agenda for growth.
And so they have boring and a lot of money.
A into life science research.
Manufactures -- moving into Asia as well.
-- -- the trend to reduce health care costs and I I think we're writing that -- both on the research side.
As well as on the manufacturing side and we find ourselves in a fairly good -- -- -- We are also looking though at a trend where fewer tests are being conducted in fact the new health care bill here in the United States which is now law.
Pushes for fewer tests and and more preventative care how to set -- -- -- good energy costs.
No it's good so we have three businesses we you know we -- researchers around the world and that's our research business.
We also into -- because applied markets in -- hoping testing of our trees develop new tests whether it's human diagnostics -- environmental diagnostics.
As so -- helping them develop -- complicated doesn't providing products you get it -- -- that -- our viewers to wrap our minds around what it is exactly that you do an environmental diagnostic correct so.
In my -- diagnostics that even predicting failures of transformers and industrial setting where he can sample gases.
And predict when it -- homo would fail so that.
But more -- they'll just put -- -- utility companies can change that.
You know we are supplying.
-- a -- -- China for.
-- test for a stomach ounces it's an isotope that -- provide.
Very you know practice and it's selling really well in China so we do different kind of does -- have.
Great comfort come to get a vitamin.
You know -- 200000 products that we take to the market as we don't have a single product that makes up more than 2% -- -- sales.
And we have a room over a million customers so we have a very diversified as -- company 9000.
Employees are you hiring and if so where which countries.
We have been hiding I I would say that right now candy -- brought that in the emerging markets in Asia and Latin America is stronger than the rest of the world.
We have been hiding -- but we have not stop hiding.
And the US and Europe we have quite Euro centric we have -- 40% of our business and Europe.
And so we continue to see -- -- -- -- -- -- cautious with what's happening.
In the global macro environment.
You know their fiscal precious -- on funding on research so we we -- carefully.
But we -- optimistic cautiously optimistic about the outlook we love to hear this.
Prakash soft stuff thank you so much for joining us the company is called Sigma-Aldrich -- you don't know the ticker symbol it's SRI -- Up 18% year for -- and it's exciting time for your company thank you.
Filter by section